Ulrich h. Koszinowski

Ulrich h. Koszinowski's AcademicInfluence.com Rankings

Biology

#8274

World Rank

#11324

Historical Rank

Virology

#179

World Rank

#184

Historical Rank

Immunology

#467

World Rank

#484

Historical Rank

biology Degrees

Download Badge

Biology

Ulrich h. Koszinowski's Degrees

PhD Virology University of Tübingen

Why Is Ulrich h. Koszinowski Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ulrich h. Koszinowski's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes (1989) (2128)
Viral mechanisms of immune evasion (2000) (526)
Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes (2004) (472)
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. (1997) (455)
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity (1987) (449)
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs (1985) (445)
Cloning of the Human Cytomegalovirus (HCMV) Genome as an Infectious Bacterial Artificial Chromosome in Escherichia coli: a New Approach for Construction of HCMV Mutants (1999) (394)
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. (2008) (392)
Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection (1998) (384)
Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time 1 (2003) (353)
Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses (2003) (347)
Systematic Excision of Vector Sequences from the BAC-Cloned Herpesvirus Genome during Virus Reconstitution (1999) (347)
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. (1997) (345)
Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes (1994) (344)
Cloning and Mutagenesis of the Murine Gammaherpesvirus 68 Genome as an Infectious Bacterial Artificial Chromosome (2000) (343)
A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes (1989) (338)
Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein (1991) (337)
Viral mechanisms of immune evasion (2000) (334)
A role for the proteasome regulator PA28α in antigen presentation (1996) (333)
Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands (1996) (312)
Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus (1994) (296)
Cytomegalovirus Recruitment of Cellular Kinases to Dissolve the Nuclear Lamina (2002) (294)
A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. (1997) (284)
Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands (1992) (261)
A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation (1999) (259)
Fast Screening Procedures for Random Transposon Libraries of Cloned Herpesvirus Genomes: Mutational Analysis of Human Cytomegalovirus Envelope Glycoprotein Genes (2000) (257)
Memory Inflation: Continous Accumulation of Antiviral CD8+ T Cells Over Time (2003) (248)
Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus (2004) (247)
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life (2009) (228)
Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. (1998) (228)
The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease (1994) (227)
A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. (1996) (221)
Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment (1992) (216)
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes (1990) (216)
A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface (1997) (213)
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. (2010) (211)
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. (2001) (211)
Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes (1987) (210)
A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus. (1985) (202)
Major Histocompatibility Complex Class I Allele-specific Cooperative and Competitive Interactions between Immune Evasion Proteins of Cytomegalovirus (2002) (189)
Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. (2006) (187)
Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. (2003) (186)
Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes (2000) (184)
Degradation of Cellular miR-27 by a Novel, Highly Abundant Viral Transcript Is Important for Efficient Virus Replication In Vivo (2012) (184)
Natural Killer Cells Promote Early CD8 T Cell Responses against Cytomegalovirus (2007) (183)
Evolutionarily Conserved Herpesviral Protein Interaction Networks (2009) (177)
Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection (1984) (175)
Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. (1994) (171)
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145 (2004) (170)
Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus (1975) (168)
Role of Murine Cytomegalovirus US22 Gene Family Members in Replication in Macrophages (2003) (168)
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-γ signaling and antiviral responses (2005) (163)
A Mouse Model for Cytomegalovirus Infection (2001) (161)
Structural Basis of Vesicle Formation at the Inner Nuclear Membrane (2015) (158)
Sequence and structural organization of murine cytomegalovirus immediate-early gene 1 (1987) (152)
A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection (1988) (151)
K3-mediated evasion of CD8+ T cells aids amplification of a latent γ-herpesvirus (2002) (150)
Viruses know it all: new insights into IFN networks. (2005) (150)
Molecular cloning and physical mapping of murine cytomegalovirus DNA (1983) (142)
Frequent Coinfection of Cells Explains Functional In Vivo Complementation between Cytomegalovirus Variants in the Multiply Infected Host (2005) (141)
HCMV Spread and Cell Tropism are Determined by Distinct Virus Populations (2011) (140)
Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope (1991) (140)
Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3 (1992) (139)
Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. (1993) (138)
The cleavage preference of the proteasome governs the yield of antigenic peptides (1995) (137)
Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89 (1988) (136)
Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1. (2001) (134)
The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus against T Cell Control in Vivo (1999) (134)
Cellular and molecular basis of the protective immune response to cytomegalovirus infection. (1990) (133)
The Sequence Alteration Associated with a Mutational Hotspot in p53 Protects Cells From Lysis by Cytotoxic T Lymphocytes Specific for a Flanking Peptide Epitope (1998) (132)
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response (2009) (129)
Virus Progeny of Murine Cytomegalovirus Bacterial Artificial Chromosome pSM3fr Show Reduced Growth in Salivary Glands due to a Fixed Mutation of MCK-2 (2011) (128)
The Human Cytomegalovirus Ribonucleotide Reductase Homolog UL45 Is Dispensable for Growth in Endothelial Cells, as Determined by a BAC-Cloned Clinical Isolate of Human Cytomegalovirus with Preserved Wild-Type Characteristics (2002) (127)
Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape (1994) (125)
Cytomegaloviral control of MHC class I function in the mouse (1999) (119)
Selective Down-Regulation of the NKG2D Ligand H60 by Mouse Cytomegalovirus m155 Glycoprotein (2005) (119)
The Murine Cytomegalovirus Immunomodulatory Gene m152 Prevents Recognition of Infected Cells by M45-Specific CTL But Does Not Alter the Immunodominance of the M45-Specific CD8 T Cell Response In Vivo1 (2002) (119)
Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase (1989) (118)
Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host (1988) (118)
Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis (1999) (117)
Forward with BACs: new tools for herpesvirus genomics. (2000) (117)
Herpesvirus genetics has come of age. (2002) (116)
Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection. (1993) (115)
Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection (1984) (115)
The Multiple Immune-Evasion Genes of Murine Cytomegalovirus Are Not Redundant (2001) (115)
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. (2008) (114)
Escape of mutant double-stranded DNA virus from innate immune control. (2004) (114)
Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses (2004) (114)
The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage‐specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors (1984) (113)
Mouse Cytomegalovirus MicroRNAs Dominate the Cellular Small RNA Profile during Lytic Infection and Show Features of Posttranscriptional Regulation (2007) (112)
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60 (2006) (111)
Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products (1987) (109)
A role for the proteasome regulator PA28alpha in antigen presentation. (1996) (108)
K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. (2002) (108)
UL74 of Human Cytomegalovirus Contributes to Virus Release by Promoting Secondary Envelopment of Virions (2008) (106)
Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. (1996) (104)
T-cell cytotoxicity in the absence of viral protein synthesis in target cells (1977) (102)
Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus (1985) (102)
Use of a Murine Cytomegalovirus K181-Derived Bacterial Artificial Chromosome as a Vaccine Vector for Immunocontraception (2005) (99)
Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. (1988) (99)
Monoclonal antibodies reactive with swine lymphocytes. I. Antibodies to membrane structures that define the cytolytic T lymphocyte subset in the swine. (1984) (99)
Interference with antigen processing by viruses. (1997) (97)
Target cell‐dependent T cell‐mediated lysis of vaccinia virus‐infected cells (1975) (97)
The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules (2000) (96)
Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport (1995) (95)
Virus Reconstituted from Infectious Bacterial Artificial Chromosome (BAC)-Cloned Murine Gammaherpesvirus 68 Acquires Wild-Type Properties In Vivo Only after Excision of BAC Vector Sequences (2001) (95)
Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus (1992) (93)
Metabolic labeling of newly transcribed RNA for high resolution gene expression profiling of RNA synthesis, processing and decay in cell culture. (2013) (92)
The Ribonucleotide Reductase R1 Homolog of Murine Cytomegalovirus Is Not a Functional Enzyme Subunit but Is Required for Pathogenesis (2004) (91)
Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 (2004) (87)
Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor (1994) (87)
Characterization of the murine cytomegalovirus early transcription unit e1 that is induced by immediate-early proteins (1990) (86)
Comprehensive Mutational Analysis of a Herpesvirus Gene in the Viral Genome Context Reveals a Region Essential for Virus Replication (2004) (85)
Functional Domains of Murine Cytomegalovirus Nuclear Egress Protein M53/p38 (2006) (84)
The 89,000-Mr murine cytomegalovirus immediate-early protein activates gene transcription (1986) (84)
Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control (1998) (83)
Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the α3 domain of MHC I molecules (1991) (81)
In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection (1987) (81)
The Murine Cytomegalovirus Immune Evasion Protein m4/gp34 Forms Biochemically Distinct Complexes with Class I MHC at the Cell Surface and in a Pre-Golgi Compartment1 (2001) (80)
Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. (2003) (80)
Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. (1995) (78)
The role of CD4 and CD8 T cells in viral infections. (1991) (78)
Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus [published erratum appears in J Exp Med 1987 Nov 1;166(5):following 1608] (1987) (76)
Coordinated Function of Murine Cytomegalovirus Genes Completely Inhibits CTL Lysis1 (2006) (76)
Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. (1996) (75)
Viral Interference with B7-1 Costimulation: A New Role for Murine Cytomegalovirus Fc Receptor-11 (2006) (72)
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. (2004) (71)
Structure and expression of murine cytomegalovirus immediate-early gene 2 (1991) (71)
The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus. (1984) (69)
Macrophages Escape Inhibition of Major Histocompatibility Complex Class I-Dependent Antigen Presentation by Cytomegalovirus (2000) (69)
A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes (1987) (68)
Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. (2010) (68)
Cytomegalovirus microRNAs Facilitate Persistent Virus Infection in Salivary Glands (2010) (67)
The Viral Chemokine MCK-2 of Murine Cytomegalovirus Promotes Infection as Part of a gH/gL/MCK-2 Complex (2013) (66)
Enhancer Requirement for Murine Cytomegalovirus Growth and Genetic Complementation by the Human Cytomegalovirus Enhancer (1998) (65)
The proteasome regulator PA28α/β can enhance antigen presentation without affecting 20S proteasome subunit composition (2000) (65)
Inactivation of a Defined Active Site in the Mouse 20S Proteasome Complex Enhances Major Histocompatibility Complex Class I Antigen Presentation of a Murine Cytomegalovirus Protein (1998) (64)
T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function. (1982) (64)
Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8 (1998) (63)
Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus (1986) (63)
Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down-regulated after activation. (1987) (61)
Protection from Inflammatory Organ Damage in a Murine Model of Hemophagocytic Lymphohistiocytosis Using Treatment with IL-18 Binding Protein (2012) (61)
Recognition of viral glycoproteins by influenza A-specific cross- reactive cytolytic T lymphocytes (1980) (61)
AP‐1A and AP‐3A Lysosomal Sorting Functions (2002) (60)
Dominant-Negative FADD Rescues the In Vivo Fitness of a Cytomegalovirus Lacking an Antiapoptotic Viral Gene (2007) (60)
A Gammaherpesvirus G Protein-Coupled Receptor Homologue Is Required for Increased Viral Replication in Response to Chemokines and Efficient Reactivation from Latency1 2 (2003) (58)
The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. (2003) (57)
Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors (1988) (55)
Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes (1986) (54)
Common and Specific Properties of Herpesvirus UL34/UL31 Protein Family Members Revealed by Protein ComplementationAssay (2006) (54)
Targeted Deletion of Regions Rich in Immune-Evasive Genes from the Cytomegalovirus Genome as a Novel Vaccine Strategy (2007) (52)
IFN-gamma is a prerequisite for optimal antigen processing of viral peptides in vivo. (1997) (52)
Development of bovine herpesvirus 4 as an expression vector using bacterial artificial chromosome cloning. (2005) (50)
Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes (1987) (48)
Mutagenesis of viral BACs with linear PCR fragments (ET recombination). (2004) (46)
Intact NKG2D-Independent Function of NK Cells Chronically Stimulated with the NKG2D Ligand Rae-1 (2010) (46)
Effective Inhibition of Kb- and Db-Restricted Antigen Presentation in Primary Macrophages by Murine Cytomegalovirus (2003) (46)
Differential Susceptibility of RAE-1 Isoforms to Mouse Cytomegalovirus (2009) (45)
Altered serological and cellular reactivity to H-2 antigens after target cell infection with vaccinia virus (1975) (45)
A Spread-Deficient Cytomegalovirus for Assessment of First-Target Cells in Vaccination (2010) (45)
Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. (1990) (44)
Human Cytomegalovirus Disrupts the Major Histocompatibility Complex Class I Peptide-Loading Complex and Inhibits Tapasin Gene Transcription (2011) (43)
Detection of antibodies to Sendai virus by enzyme-linked immunosorbent assay (ELISA). (1979) (42)
The m74 Gene Product of Murine Cytomegalovirus (MCMV) Is a Functional Homolog of Human CMV gO and Determines the Entry Pathway of MCMV (2010) (42)
MHC Class I Cross-Presentation by Dendritic Cells Counteracts Viral Immune Evasion (2012) (41)
Selective inhibition of T suppressor-cell function by a monosaccharide (1981) (39)
Conditional Cytomegalovirus Replication In Vitro and In Vivo (2005) (39)
Vaccination of Mice with Bacteria Carrying a Cloned Herpesvirus Genome Reconstituted In Vivo (2003) (38)
A Novel Murine Cytomegalovirus Vaccine Vector Protects against Mycobacterium tuberculosis (2014) (38)
Nuclear Herpesvirus Capsid Motility Is Not Dependent on F-Actin (2014) (37)
Studies on the morphogenesis of murine cytomegalovirus. (1986) (36)
Dominant Negative Mutants of the Murine Cytomegalovirus M53 Gene Block Nuclear Egress and Inhibit Capsid Maturation (2010) (35)
Monoclonal antibodies reactive with swine lymphocytes (1984) (33)
Serial detection of Epstein–Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis‐like symptoms defines patients at risk to develop post‐transplant lymphoproliferative disease (2003) (33)
Role of early viral surface antigens in cellular immune response to vaccinia virus (1976) (33)
Shedding Light on the Elusive Role of Endothelial Cells in Cytomegalovirus Dissemination (2011) (32)
M94 Is Essential for the Secondary Envelopment of Murine Cytomegalovirus (2011) (32)
Transposon-Assisted Cloning and Traceless Mutagenesis of Adenoviruses: Development of a Novel Vector Based on SpeciesD (2006) (32)
Rescue of myeloid lineage-committed preprogenitor cells from cytomegalovirus-infected bone marrow stroma (1991) (32)
The making of the dominant MHC class I ligand SYFPEITHI (1998) (31)
Random Screening for Dominant-Negative Mutants of the Cytomegalovirus Nuclear Egress Protein M50 (2007) (31)
Distribution of T-lymphocyte subsets in porcine lymphoid tissues. (1987) (31)
The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition. (2000) (31)
The role of cell types in cytomegalovirus infection in vivo. (2012) (30)
Redistribution of critical major histocompatibility complex and T cell receptor‐binding functions of residues in an antigenic sequence after biterminal substitution (1991) (30)
Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus. (1994) (29)
Characterization of the murine cytomegalovirus genes encoding the major DNA binding protein and the ICP18.5 homolog. (1992) (29)
Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. (1987) (28)
Block of Death-Receptor Apoptosis Protects Mouse Cytomegalovirus from Macrophages and Is a Determinant of Virulence in Immunodeficient Hosts (2012) (28)
Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus. (1989) (28)
The 89,000-Mr murine cytomegalovirus immediate-early protein stimulates c-fos expression and cellular DNA synthesis (1988) (28)
Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes (2009) (28)
The Glycoprotein gp48 of Murine Cytomegalovirus (2002) (25)
Cytomegalovirus bacterial artificial chromosomes: a new herpesvirus vector approach. (2000) (24)
Mouse cytomegalovirus egress protein pM50 interacts with cellular endophilin‐A2 (2013) (24)
Strategies for the identification and analysis of viral immune-evasive genes--cytomegalovirus as an example. (2002) (23)
HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope1 (2001) (23)
Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. (2013) (23)
Conditional gene expression systems to study herpesvirus biology in vivo (2008) (22)
Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines. (2008) (21)
An acidic region of the 89K murine cytomegalovirus immediate early protein interacts with DNA. (1992) (18)
A Beta-Herpesvirus with Fluorescent Capsids to Study Transport in Living Cells (2012) (18)
Dissection of the antiviral NK cell response by MCMV mutants. (2008) (18)
Murine cytomegalovirus genomic material in marrow cells: relation to altered leukocyte counts during sublethal infection of mice. (1987) (17)
Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs. (2001) (17)
Characterization of Conserved Region 2-Deficient Mutants of the Cytomegalovirus Egress Protein pM53 (2012) (17)
Interferon " y Stimulation Modulates the Proteolytic Activity and Cleavage Site Preference of 20 S Mouse Proteasomes (1994) (15)
Interaction of the 89K murine cytomegalovirus immediate-early protein with core histones. (1988) (15)
Mutagenesis of the cytomegalovirus genome. (2008) (15)
Viral mechanisms of immune evasion (2000) (13)
Principles of cytomegalovirus antigen presentation in vitro and in vivo. (1992) (13)
Transposon-Assisted Cloning and Traceless Mutagenesis of Adenoviruses: Development of a Novel Vector Based on Species D (2006) (13)
Frequency analysis of cytolytic T lymphocyte precursors (CTL‐P) generated in vivo during lethal rabies infection of mice. II. Rabies virus genus specificity of CTL‐P (1984) (12)
Cytomegalovirus microRNAs (2009) (12)
The limits of protection by “memory” T cells in Ig–/– mice persistently infected with a γ-herpesvirus (2004) (11)
Recognition of alterations induced by early vaccinia surface antigens and dependence of virus-specific lysis on H-2 antigen concentration on target cells. (1977) (10)
Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. (1995) (10)
Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2. (1987) (10)
Proteins of the secretory pathway govern virus productivity during lytic gammaherpesvirus infection (2008) (9)
The polyomaviruses WUPyV and KIPyV: a retrospective quantitative analysis in patients undergoing hematopoietic stem cell transplantation (2012) (9)
A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complex. (2012) (9)
The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus. (2004) (9)
Pathogenesis of Murine Cytomegalovirus Infection in Neonatal Mice (1998) (9)
PA28αβ double and PA28β single transfectant mouse B8 cell lines reveal enhanced presentation of a mouse cytomegalovirus (MCMV) pp89 MHC class I epitope (2000) (9)
Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL. (1980) (9)
The core histone-binding region of the murine cytomegalovirus 89K immediate early protein. (1991) (8)
Viral Proteins Counteracting Host Defenses (2002) (8)
Modification of H-2 antigenic sites by enzymatic treatment influences virus-specific target cell lysis. (1976) (8)
Cytomegalovirus Replicon-Based Regulation of Gene Expression In Vitro and In Vivo (2012) (7)
Dominant-Negative Proteins in Herpesviruses – From Assigning Gene Function to Intracellular Immunization (2009) (7)
Cell-mediated cytotoxicity against Sendai-virus-infected cells. (1976) (7)
Location, transcripts, and translation products (1987) (7)
Cytomegalovirus persistence by evasion from immune control (1994) (7)
Virus-specific t-cell sensitization. Requirements for vaccinia virus-specific t-cell sensitization in vivo. (1977) (7)
Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumor. (1981) (6)
Rapid Enzymatic Test for Phenotypic HIV Protease Drug Resistance (2003) (6)
Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs. (1975) (6)
Molecular aspects of immune recognition of cytomegalovirus. (1991) (6)
Generation of effector cells from T cell subsets. I. Similar requirements for Lyt T cell subpopulations in the generation of alloreactive and H-2 restricted killer cells. (1979) (6)
The Murine Cytomegalovirus (2002) (6)
In-vitro demonstration of cell-mediated immunity to vaccinia virus in man. (1975) (5)
Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells. (1979) (5)
Interactions between vaccinia virus and sensitized macrophagesin vitro (2005) (4)
Involvement of Mhc Loci in immune responses that are not Ir-gene-controlled (2004) (4)
[In vitro stimulation of lymphocytes of HB antibody carriers by HB antigen (Australia antigen)]. (1973) (4)
A Vaccine Monkey Wrench? (2010) (4)
T Cells Over Time + of Antiviral CD 8 Memory Inflation : Continuous Accumulation (2003) (4)
Inactivation of PRIM 1 Function Sensitizes Cancer Cells to ATR and CHK 1 Inhibitors 1 (2003) (3)
The Innate Immune Response to Infection Induces Erythropoietin-Dependent Replenishment of the Dendritic Cell Compartment (2020) (3)
CYTOTOXIC INTERACTIONS OF VIRUS SPECIFIC EFFECTOR CELLS WITH VIRUS INFECTED TARGETS OF DIFFERENT CELL TYPE * (1977) (3)
Characterization of a conserved gene block in the murine cytomegalovirus genome (2005) (3)
Virus-specific T-cell sensitization (1977) (3)
A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in a lack of antigen presentation (1997) (3)
Host immune response to cytomegalovirus (1987) (2)
GammaInterferon-Dependent Clearance ofCytomegalovirus Infection inSalivary Glands (1992) (2)
Systemic and Local Infection Routes Govern Different Cellular Dissemination Pathways during Gammaherpesvirus Infection In Vivo (2013) (2)
Increased cellular immunity against host cell antigens induced by vacciniavirus (2005) (2)
Erratum: Memory inflation: Continous accumulation of antiviral CD8 + T cells over time (Journal of Immunology (2003) 170 (2022-2029)) (2003) (2)
Emptying Pandora's box: cytosolic export and MHC degradation. (1996) (2)
CYTOTOXICITY AFTER B.C.G. INFECTION (1974) (2)
Regulatory counteraction to IL-2 activity. (1983) (2)
Common and Speciﬁc Properties of Herpesvirus UL34/UL31 Protein Family Members Revealed by Protein Complementation Assay (cid:1) (2006) (2)
Viral Interference with the Host Immune Response (2010) (2)
Evolution and divergence of herpesviral protein interaction networks (2009) (1)
Viral mechanisms of immune (2000) (1)
Subject Index, Vol. 26, 1986 (1986) (1)
Inhibition of MHC Class I Function by Cytomegalovirus (2002) (1)
Intracellular receptors for viral and bacterial infections (PP-056) (2010) (1)
A mouse cytomegalovirus glycoprotein blocks the transport of nascent MHC class I molecules to the plasma membrane (1995) (1)
The herpesviral Fc eceptor fcr-1 as a potent Down-regulator of the NKG2D ligand MULT-1 and H60 (2006) (1)
Viral functions and immune modulation. (2012) (1)
SECONDARY SENDAI-SPECIFIC T-EFFECTOR CELLS: REQUIREMENTS FOR RESTIMULATION, TARGET CELLS RECOGNITION, AND LYSIS (1979) (1)
CHARACTERIZATION OF MURINE CYTOMEGALOVIRUS 34 KDA GLYCOPROTEIN THAT FORMS A COMPLEX WITH THE CELL-SURFACE MHC CLASS I MOLECULES (1998) (0)
Molecular Analysis of the Protective Immune Response to Murine Cytomegalovirus (1989) (0)
ANALYSIS OF REQUIREMENTS FOR CELL MEDIATED LYSIS INTERACTION BETWEEN VIRAL GLYCOPROTEINS AND CELL PLASMA MEMBRANES (1979) (0)
of Antiviral CD8+ T Cells Over Time Memory Inflation: Continuous Accumulation (2013) (0)
NKG2D Ligand Rae-1 Cells Chronically Stimulated with the Intact NKG2D-Independent Function of NK (2010) (0)
MHC class I regulatory genes of CMV. Are they pathogenicity genes (1999) (0)
This information is current as CD 8 T Cell Response Size or the Effector Memory Phenotype of the Antigen Presentation Has Little Effect on the Murine Cytomegalovirus Interference with (2004) (0)
[Enhanced immunogenicity of murine liver cells infected by MHV-3 (author's transl)]. (1974) (0)
T Cell Response In Vivo Immunodominance of the M 45-Specific CD 8 CTL But Does Not Alter the Recognition of Infected Cells by M 45-Specific Prevents m 152 Immunomodulatory Gene The Murine Cytomegalovirus (2002) (0)
Perturbation of liver function in MCMV-induced hepatitis (2002) (0)
Immune evasion potential of the murine cytomegalovirus gene m04 (1997) (0)
Cytotoxic interactions of virus-specific effector cells with virus-infected targets of different cell type [proceedings]. (1976) (0)
Microbial Subversion of NK cell Function (2006) (0)
Explorer Evolutionarily Conserved Herpesviral Protein Interaction Networks (2017) (0)
PA28alphabeta double and PA28beta single transfectant mouse B8 cell lines reveal enhanced presentation of a mouse cytomegalovirus (MCMV) pp89 MHC class I epitope. (2000) (0)
Foreign H-2-like ,olecules on a murine tumor (MCG4) (1980) (0)
Differential susceptibility of RAE-1 proteins to down-regulation by MCMV m152 (2008) (0)
Book review (2005) (0)
In vivo potential of m152 gene of murine cytomegalovirus to evade control by MHC class I restricted T cells (1997) (0)
The human cytomegalovirus-encoded US6 glycoprotein inhibits the transporter associated with antigen processing (1997) (0)
The product of m152 gene enables murine cytomegalovirus to evade control by MHC class I restricted T lymphocytes in vivo (1998) (0)
A mouse cytomegalovirus glycoprotein , gp 34 , forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface ing presentation of peptide by MHC class I molecules (2013) (0)
[Cellular immunity to HB-antigen (Australia antigen)--in-vitro reactions in guinea pigs and humans (author's transl)]. (1974) (0)
Structure andExpression ofMurineCytomegalovirus Immediate-Early Gene2 (1991) (0)
Chemokines and Efficient Reactivation from Increased Viral Replication in Response to Receptor Homologue Is Required for A Gammaherpesvirus G Protein-Coupled (2002) (0)
Efficacious avoidance of CD8+ and NK cells-mediated virus control by MCMV m152 gene product (2002) (0)
Immunity to virus infection (excluding retroviruses) 2 (WS-025b) Chairpersons: Tsukasa Seya, Iain Campbell (2010) (0)
Structure and Expression of Murine Cytomegalovirus Immediate-Early Gene 2 MARTIN MESSERLE , ' (2003) (0)
Receptor-1 A New Role for Murine Cytomegalovirus Fc Viral Interference with B 7-1 Costimulation : (2006) (0)
[Increased immunogenicity of plasma membranes of BHK-cells infected by vaccinia virus]. (1973) (0)
Immunological reactivity of a consensus sequence of the HIV-1 principal neutralizing determinant V3 (1993) (0)
Erratum: The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection (Journal of General Virology vol. 84 (3359-3370)) (2004) (0)
Deletion of MCMV m157 gene reveals the function of NKG2D silencing viral genes also in CMV1 positive mice (2005) (0)
Maja due to a Fixed Mutation of MCK-2 Show Reduced Growth in Salivary Glands Bacterial Artificial Chromosome pSM 3 fr Virus Progeny of Murine Cytomegalovirus (2011) (0)
The limits of protection by ‘‘memory’’ T cells in Ig / (cid:1) mice persistently infected with a (cid:2) -herpesvirus (2004) (0)
The persistence of recombinant adenoviral vectors (2009) (0)
Epitope Presentation of a Cytomegalovirus Protective HIV Envelope Protein Inhibits MHC Class I (2001) (0)
The persistence of recombinant adenoviral vectors (2009) (0)
In Vivo Infection during Gammaherpesvirus Govern Different Cellular Dissemination Systemic and Local Infection Routes (2014) (0)
I am grateful to Dr. G. Della Porta for helpful discussion during the course of these studies. The skillful technical assistance of Ms. Liliana Panni and Mr. Carlo Brunati is acknowledged. (1975) (0)
The polyomaviruses WUPyV and KIPyV: a retrospective quantitative analysis in patients undergoing hematopoietic stem cell transplantation (2012) (0)
I am grateful to Dr. G. Della Porta for helpful discussion during the course of these studies. The skillful technical assistance of Ms. Liliana Panni and Mr. Carlo Brunati is acknowledged. (1975) (0)
CYTOMEGALOVIRUS PERSISTENCE IN SALIVARY GLANDS BY EVASION IMMUNOLOGICAL CONTROL (1994) (0)
Cd8+ T Cell Evasion by K3 during Gamma-Herpesvirus Latency Establishment (2002) (0)
Letter: Cytotoxicity after B.C.G. infection. (1974) (0)
Quantitative Analysis of Activated Cytolytic T Lymphocytes Present in Vivo After Infection with the Murine Cytomegalovirus (1984) (0)
Inactivation of the transporter associated with antigen processing (TAP) by a viral ER-resident glycoprotein (1997) (0)
Murine cytomegalovirus glycoproteins that interfere with the MHC class I antigen presentation pathway (1996) (0)
Cell Surface and in a Pre-Golgi Biochemically Distinct Complexes with Class Evasion Protein m 4 / gp 34 Forms The Murine Cytomegalovirus Immune (2001) (0)
A Modified Screening System for Loss-of-Function and Dominant Negative Alleles of Essential MCMV Genes (2014) (0)
Conversion of latent to recurrent MCMV infection is primarily controlled by CD8+ T lymphocytes and NK cells (2002) (0)
The Innate Immune Response to Infection Induces Erythropoietin-Dependent Replenishment of the Dendritic Cell (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ulrich h. Koszinowski?

Ulrich h. Koszinowski is affiliated with the following schools:

Ulrich h. Koszinowski's Academic­Influence.com Rankings

Ulrich h. Koszinowski's Degrees

Why Is Ulrich h. Koszinowski Influential?

Ulrich h. Koszinowski's Published Works

Published Works

What Schools Are Affiliated With Ulrich h. Koszinowski?

Ulrich h. Koszinowski's AcademicInfluence.com Rankings